Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.15 USD | +1.99% | -1.80% | +9.68% |
Business Summary
Number of employees: 112
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 17/04/22 |
Chief Tech/Sci/R&D Officer | - | 30/06/17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 23/05/18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 06/11/22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 16/01/19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 31/12/16 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 31/08/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 07/06/17 |
Harold Selick
CHM | Chairman | 69 | 31/01/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 25/10/23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 11/08/20 |
William Waddill
BRD | Director/Board Member | 67 | 30/06/16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 15/05/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,274,998 | 56,835,300 ( 97.53 %) | 0 | 97.53 % |
Company contact information
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.68% | 1.47B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PTGX Stock
- Company Protagonist Therapeutics, Inc.